Exchange: NYSE·Updated 07:27 PM EDT
AORT logo

AORTArtivion Inc

$23.90
$1.08
(4.81%)
Today
Closed $23.55
$0.3504
(1.49%)
After Hours
EarningsAug 6
Mkt Cap$1.09B
Vol854,120.00
News
all
press releases
Artivion Secures FDA Approval for AMDS Hybrid Prosthesis Device
AORT's FDA approval for AMDS removes a key hospital adoption hurdle and opens access to an estimated $150 million annual U.S. market.
Zacks
News Placeholder
More News
News Placeholder
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval
Artivion secured FDA PMA approval for AMDS, removing IRB hurdles and expanding access for acute aortic dissection patients.read more...
Benzinga
News Placeholder
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis PR Newswire ATLANTA, June 29, 2026 ATLANTA, June 29, 2026 /PRNewswire/ --Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on...
PR Newswire
News Placeholder
Oversold Conditions For Artivion (AORT)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...
Nasdaq News: Markets
News Placeholder
Artivion to Participate in the 2026 Truist Securities MedTech Conference
Artivion to Participate in the 2026 Truist Securities MedTech Conference Artivion to Participate in the 2026 Truist Securities MedTech Conference PR Newswire ATLANTA, June 10, 2026 ATLANTA, June 10, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company...
PR Newswire
News Placeholder
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS Aortic Arch System
Endospan, a pioneer in endovascular solutions for complex aortic pathologies, today announced that Artivion, Inc. (NYSE: AORT) has closed the transaction to acquire the company. This strategic...
Business Wire
News Placeholder
Artivion Completes Acquisition of Endospan Ltd.
Artivion Completes Acquisition of Endospan Ltd. Artivion Completes Acquisition of Endospan Ltd. PR Newswire ATLANTA, May 18, 2026 ATLANTA, May 18, 2026 Artivion, Inc. (NYSE: AORT), a leading cardiac...
PR Newswire
News Placeholder
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc.
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc. Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc. PR Newswire...
PR Newswire
News Placeholder
Crude Oil Gains 1%; Fluor Shares Plunge After Q1 Results
US stocks traded higher, Nasdaq gained 1.5%. Dow down 0.06%. IT shares up 2.1% while healthcare stocks fell 0.9%. Fluor shares dropped 12% due to weak earnings. Westrock Coffee, Innodata, and Nlight...
Benzinga
News Placeholder
Artivion (AORT) Q1 Earnings and Revenues Surpass Estimates
Artivion (AORT) delivered earnings and revenue surprises of +33.33% and +0.33%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>

Advertisement|Remove ads.